The stock has demonstrated a strong overall uptrend over the last six months, rising 42.2% from a close of $13.23 on October 2, 2025, to $18.81 on March 31, 2026. This performance significantly outpaced the broader market, as indicated by a 6-month relative strength of 45.0. Short-term performance shows recent volatility; the stock declined 7.2% over the past month but remains up 20.3% over the last three months, again outperforming the market with a 3-month relative strength of 25.0. The current price of $18.81 sits near the upper end of its 52-week range of $10.84 to $20.86, approximately 10% below the yearly high. The stock's beta of 0.93 suggests it has been slightly less volatile than the market during this period.

Revenue and profitability have been mixed. The most recent quarterly revenue of $2.28 billion for Q4 2025 showed a slight year-over-year decline of 1.3%. Profitability was weak in Q4, with a net loss of $78 million (net margin of -3.4%), a significant reversal from a net income of $42 million (net margin of 1.9%) in the prior quarter. The company maintains a strong financial position with a healthy current ratio of 2.42 and a moderate debt-to-equity ratio of 0.37. Cash flow generation is robust, with trailing twelve-month free cash flow of $876 million and positive operating cash flow of $573 million in the latest quarter. Operational efficiency metrics are currently subdued, with a Return on Equity (ROE) of 2.3% and a Return on Assets (ROA) of 3.7%, reflecting the recent quarterly challenges.